Bleakley Financial Group LLC Boosts Stock Holdings in The Cooper Companies, Inc. (NASDAQ:COO)

Bleakley Financial Group LLC lifted its holdings in shares of The Cooper Companies, Inc. (NASDAQ:COO) by 2.1% in the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 5,767 shares of the medical device company’s stock after buying an additional 119 shares during the period. Bleakley Financial Group LLC’s holdings in Cooper Companies were worth $636,000 at the end of the most recent reporting period.

Other institutional investors have also recently modified their holdings of the company. Quantbot Technologies LP purchased a new stake in Cooper Companies during the first quarter worth about $2,211,000. Whittier Trust Co. grew its holdings in Cooper Companies by 298.9% during the 1st quarter. Whittier Trust Co. now owns 11,940 shares of the medical device company’s stock valued at $1,211,000 after buying an additional 8,947 shares during the last quarter. Envestnet Portfolio Solutions Inc. raised its holdings in shares of Cooper Companies by 43.1% in the second quarter. Envestnet Portfolio Solutions Inc. now owns 35,233 shares of the medical device company’s stock worth $3,076,000 after acquiring an additional 10,616 shares during the last quarter. Axxcess Wealth Management LLC lifted its holdings in Cooper Companies by 298.4% in the 1st quarter. Axxcess Wealth Management LLC now owns 8,211 shares of the medical device company’s stock valued at $833,000 after purchasing an additional 6,150 shares in the last quarter. Finally, Nordea Investment Management AB lifted its stake in shares of Cooper Companies by 315.1% during the first quarter. Nordea Investment Management AB now owns 16,120 shares of the medical device company’s stock valued at $1,642,000 after buying an additional 12,237 shares during the period. 24.39% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

COO has been the topic of a number of recent analyst reports. Morgan Stanley increased their price target on Cooper Companies from $95.00 to $104.00 and gave the stock an “equal weight” rating in a research note on Tuesday, September 10th. Needham & Company LLC reaffirmed a “hold” rating on shares of Cooper Companies in a research report on Thursday, August 29th. Robert W. Baird increased their target price on Cooper Companies from $118.00 to $125.00 and gave the stock an “outperform” rating in a research report on Thursday, August 29th. Jefferies Financial Group upgraded Cooper Companies from a “hold” rating to a “buy” rating and upped their price target for the stock from $107.00 to $115.00 in a research note on Tuesday, July 16th. Finally, Wells Fargo & Company raised their price target on shares of Cooper Companies from $110.00 to $115.00 and gave the company an “overweight” rating in a report on Thursday, August 29th. Three equities research analysts have rated the stock with a hold rating and ten have issued a buy rating to the stock. According to MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $115.00.

Cooper Companies Stock Down 1.4 %

Shares of NASDAQ:COO opened at $106.72 on Tuesday. The firm has a market cap of $21.25 billion, a PE ratio of 62.78, a price-to-earnings-growth ratio of 2.56 and a beta of 0.98. The company has a current ratio of 1.99, a quick ratio of 1.18 and a debt-to-equity ratio of 0.33. The Cooper Companies, Inc. has a 12-month low of $75.93 and a 12-month high of $112.38. The company has a fifty day simple moving average of $104.28 and a 200 day simple moving average of $96.42.

Cooper Companies (NASDAQ:COO) last posted its quarterly earnings results on Wednesday, August 28th. The medical device company reported $0.96 EPS for the quarter, topping analysts’ consensus estimates of $0.91 by $0.05. Cooper Companies had a return on equity of 9.08% and a net margin of 9.45%. The business had revenue of $1 billion during the quarter, compared to the consensus estimate of $997.30 million. During the same period last year, the firm earned $0.84 earnings per share. The company’s revenue for the quarter was up 7.8% compared to the same quarter last year. On average, equities research analysts anticipate that The Cooper Companies, Inc. will post 3.65 EPS for the current fiscal year.

Insider Buying and Selling

In other Cooper Companies news, CAO Agostino Ricupati sold 1,601 shares of the stock in a transaction on Tuesday, September 10th. The shares were sold at an average price of $108.03, for a total transaction of $172,956.03. Following the sale, the chief accounting officer now directly owns 4,818 shares of the company’s stock, valued at approximately $520,488.54. This represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. In other news, COO Daniel G. Mcbride sold 114,992 shares of the business’s stock in a transaction on Wednesday, September 4th. The shares were sold at an average price of $105.48, for a total transaction of $12,129,356.16. Following the completion of the transaction, the chief operating officer now owns 44,696 shares of the company’s stock, valued at approximately $4,714,534.08. The trade was a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. Also, CAO Agostino Ricupati sold 1,601 shares of the stock in a transaction dated Tuesday, September 10th. The stock was sold at an average price of $108.03, for a total transaction of $172,956.03. Following the completion of the sale, the chief accounting officer now directly owns 4,818 shares in the company, valued at approximately $520,488.54. This trade represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold 256,373 shares of company stock worth $27,637,427 over the last ninety days. 2.00% of the stock is owned by insiders.

Cooper Companies Profile

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.